40
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Induction of Type I and Type III Interferons by Borrelia burgdorferi Correlates with Pathogenesis and Requires Linear Plasmid 36

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The capacity for Borrelia burgdorferi to cause disseminated infection in humans or mice is associated with the genotype of the infecting strain. The cytokine profiles elicited by B. burgdorferi clinical isolates of different genotype (ribosomal spacer type) groups were assessed in a human PBMC co-incubation model. RST1 isolates, which are more frequently associated with disseminated Lyme disease in humans and mice, induced significantly higher levels of IFN-α and IFN-λ1/IL29 relative to RST3 isolates, which are less frequently associated with disseminated infection. No differences in the protein concentrations of IFN-γ, IL-1β, IL-6, IL-8, IL-10 or TNF-α were observed between isolates of differing genotype. The ability of B. burgdorferi to induce type I and type III IFNs was completely dependent on the presence of linear plasmid (lp) 36. An lp36-deficient B. burgdorferi mutant adhered to, and was internalized by, PBMCs and specific dendritic cell (DC) subsets less efficiently than its isogenic B31 parent strain. The association defect with mDC1s and pDCs could be restored by complementation of the mutant with the complete lp36. The RST1 clinical isolates studied were found to contain a 2.5-kB region, located in the distal one-third of lp36, which was not present in any of the RST3 isolates tested. This divergent region of lp36 may encode one or more factors required for optimal spirochetal recognition and the production of type I and type III IFNs by human DCs, thus suggesting a potential role for DCs in the pathogenesis of B. burgdorferi infection.

          Related collections

          Most cited references89

          • Record: found
          • Abstract: found
          • Article: not found

          IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.

          We report here the identification of a ligand-receptor system that, upon engagement, leads to the establishment of an antiviral state. Three closely positioned genes on human chromosome 19 encode distinct but paralogous proteins, which we designate interferon-lambda1 (IFN-lambda1), IFN-lambda2 and IFN-lambda3 (tentatively designated as IL-29, IL-28A and IL-28B, respectively, by HUGO). The expression of IFN-lambda mRNAs was inducible by viral infection in several cell lines. We identified a distinct receptor complex that is utilized by all three IFN-lambda proteins for signaling and is composed of two subunits, a receptor designated CRF2-12 (also designated as IFN-lambdaR1) and a second subunit, CRF2-4 (also known as IL-10R2). Both receptor chains are constitutively expressed on a wide variety of human cell lines and tissues and signal through the Jak-STAT (Janus kinases-signal transducers and activators of transcription) pathway. This receptor-ligand system may contribute to antiviral or other defenses by a mechanism similar to, but independent of, type I IFNs.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            IDO expression by dendritic cells: tolerance and tryptophan catabolism.

            Indoleamine 2,3-dioxygenase (IDO) is an enzyme that degrades the essential amino acid tryptophan. The concept that cells expressing IDO can suppress T-cell responses and promote tolerance is a relatively new paradigm in immunology. Considerable evidence now supports this hypothesis, including studies of mammalian pregnancy, tumour resistance, chronic infections and autoimmune diseases. In this review, we summarize key recent developments and propose a unifying model for the role of IDO in tolerance induction.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              IL-28, IL-29 and their class II cytokine receptor IL-28R.

              Cytokines play a critical role in modulating the innate and adaptive immune systems. Here, we have identified from the human genomic sequence a family of three cytokines, designated interleukin 28A (IL-28A), IL-28B and IL-29, that are distantly related to type I interferons (IFNs) and the IL-10 family. We found that like type I IFNs, IL-28 and IL-29 were induced by viral infection and showed antiviral activity. However, IL-28 and IL-29 interacted with a heterodimeric class II cytokine receptor that consisted of IL-10 receptor beta (IL-10Rbeta) and an orphan class II receptor chain, designated IL-28Ralpha. This newly described cytokine family may serve as an alternative to type I IFNs in providing immunity to viral infection.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS One
                PLoS ONE
                plos
                plosone
                PLoS ONE
                Public Library of Science (San Francisco, USA )
                1932-6203
                2014
                19 June 2014
                : 9
                : 6
                : e100174
                Affiliations
                [1 ]Department of Microbiology and Immunology, New York Medical College, Valhalla, New York, United States of America
                [2 ]Division of Infectious Diseases, Department of Medicine, New York Medical College, Valhalla, New York, United States of America
                University of Kentucky College of Medicine, United States of America
                Author notes

                Competing Interests: Gary Wormser is the recipient of research grants from Immunetics, Inc.; BioRad; DiaSorin, Inc.; and BioMerieux. Dr. Wormser is a consultant for Baxter regarding Lyme disease vaccination. No competing interests exist for any other author. This does not alter the authors’ adherence to all PLoS ONE policies on sharing data and materials.

                Conceived and designed the experiments: MAK-G DL IS MMP. Performed the experiments: MAK-G DL AL MMP. Analyzed the data: MAK-G AL IS MMP. Contributed reagents/materials/analysis tools: GPW. Wrote the paper: MAK-G AL IS MMP.

                [¤]

                Current address: Division of Gastroenterology, Department of Medicine, The Icahn School of Medicine at Mount Sinai, New York, New York, United States of America

                Article
                PONE-D-12-23810
                10.1371/journal.pone.0100174
                4063763
                24945497
                1d698732-4b56-4178-a34a-171fa929b960
                Copyright @ 2014

                This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 3 August 2012
                : 23 May 2014
                Page count
                Pages: 14
                Funding
                This work was supported by a cooperative agreement (U01-CI000160) from the Centers for Disease Control and Prevention (to IS), The William and Sylvia Silberstein Foundation (to IS), ARRA supplement (3R01-AR41511) from the National Institutes of Health (to IS), and a predoctoral fellowship to MAK-G from the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Research Article
                Biology and Life Sciences
                Cell Biology
                Cellular Types
                Animal Cells
                Immune Cells
                Immunology
                Clinical Immunology
                Immunomodulation
                Immune Response
                Microbiology
                Medical Microbiology
                Microbial Pathogens
                Bacterial Pathogens
                Medicine and Health Sciences
                Infectious Diseases
                Bacterial Diseases
                Borrelia Infection
                Emerging Infectious Diseases
                Pathology and Laboratory Medicine
                Pathogenesis
                Host-Pathogen Interactions

                Uncategorized
                Uncategorized

                Comments

                Comment on this article